D-Arabinono-1,4-lactone
|
Basic information |
| Metabolite name | D-Arabinono-1,4-lactone |
 | N/A |
 |
N/A |
 |
17723 |
| Synonyms | NA |
| No. of studies | 2 |
|
Basic information |
| Metabolite name | D-Arabinono-1,4-lactone |
| N/A |
|
N/A |
|
17723 |
| Synonyms | NA |
| No. of studies | 2 |
|
Relationship between D-Arabinono-1,4-lactone and depression (count: 2) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M670 | Type2 | corticosterone + nicotinamide mononucleotide group vs. corticosterone group | Liver | C57/BL6 mouse | Down |
| Study M981 | Type1 | Abeta oligomer group vs. control group | Serum | ICR mouse | Up |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running group vs. Abeta oligomer group | Serum | ICR mouse | Down |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Down |
| Study M981 | Type2 | Abeta oligomer + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Up |